Optimizing the Safety Profile of Everolimus by Delayed Initiation in De Novo Heart Transplant Recipients: Results of the Prospective Randomized Study EVERHEART

BACKGROUND: Although everolimus potentially improves long-term heart transplantation (HTx) outcomes, its early postoperative safety profile had raised concerns and needs optimization. METHODS: This 6-month, open-label, multicenter randomized trial was designed to compare the cumulative incidence of...

Descripción completa

Detalles Bibliográficos
Autores principales: Potena, Luciano, Pellegrini, Carlo, Grigioni, Francesco, Amarelli, Cristiano, Livi, Ugolino, Maccherini, Massimo, Masciocco, Gabriella, Faggian, Giuseppe, Lilla della Monica, Paola, Gerosa, Gino, Marraudino, Nicola, Corda, Marco, Boffini, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2018
Materias:
Original Clinical Science—General
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5828375/
https://www.ncbi.nlm.nih.gov/pubmed/28930797
http://dx.doi.org/10.1097/TP.0000000000001945

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5828375/
https://www.ncbi.nlm.nih.gov/pubmed/28930797
http://dx.doi.org/10.1097/TP.0000000000001945

Ejemplares similares